Top news of the week: 18.08.2020.
#biospace #biotechnology #COVID19 #lifesciences #pharmaceuticals #coronavirus #treatment #vaccine #COVID #pandemic
Companies And Industries
Biopharmas continue to ramp up their R&D investments, analysis finds
According to an analysis conducted by BioWorld of the second-quarter 2020 financial reports filed by 120 public biopharmaceutical companies with market caps greater than $1 billion, and ...
Biopharma Update on the Novel Coronavirus: August 12
#biospace #lifesciences #biotechnology #pharmaceuticals
#COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/y2pKxN1Dxs
OpenBiopharma Update on the Novel Coronavirus: August 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
Sometimes in #biotech, when your standard E. coli just won’t cut it, something more exotic is needed. Could #extremophiles be the answer? 🤩#Gene&GreenTK @infoXTB @Deinove
https://t.co/lZtsfsSax5
OpenLife at its Limits: The Biotech Industry Embraces Extremophiles
Sometimes in biotech, when your standard E. coli just won't cut it, something more exotic is needed. Could extremophiles be the answer? Given enough time, and the right mutations, life can ...
Mission Bio raises $70M to scale single-cell cancer R&D platform https://t.co/a52BAOtcw5 https://t.co/keoxHTAx6M
OpenMission Bio raises $70M to scale single-cell cancer R&D platform
Mission Bio has raised $70 million to scale up a single-cell multi-omics technology with applications in the development of oncology drugs. The platform, which is in use at companies ...
RT @adamfeuerstein: CureVac’s $CVAC value soars after IPO, as #COVID19 vaccine manufacturers become biotech’s hottest... https://t.co/rWOI7mvpZZ via @damiangarde
OpenCureVac’s value soars after IPO, as Covid-19 vaccine manufacturers become biotech’s hottest companies
CureVac, headquartered in Germany, saw its share price nearly triple within hours of an initial public offering on Friday.
Sanofi Acquires Principia Biopharma in $3.6 Billion Deal
#biospace #lifesciences #biotechnology #pharmaceuticals
https://t.co/0o67bd4Keq
OpenSanofi Acquires Principia Biopharma in $3.6 Billion Deal
Under terms of the deal, Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash, which represents an aggregate equity value of approximately $3.68 ...
Biopharma Update on the Novel Coronavirus: August 14
#biospace #lifesciences #biotechnology #pharmaceuticals
#COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/B7n6PedR9S
OpenBiopharma Update on the Novel Coronavirus: August 14
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 14, 2020.
Biopharma Update on the Novel Coronavirus: August 17
#biospace #lifesciences #biotechnology #pharmaceuticals
#COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/xE9jrN7A6a
OpenBiopharma Update on the Novel Coronavirus: August 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.